Search results
Showing 406 to 420 of 1363 results for social care
NICE's business plan, annual report, charter, transformation story, gender pay gap report, framework agreement and other publications.
People can comment on our guidance at specific stages in its development.
People can comment on our guidance at specific stages in its development.
The appeal panel is drawn from a group of people approved by the Secretary of State for Health and Social Care to hear appeals.
temperature alert systems be linked from a smart meter to a health or social care provider? Any explanatory notes(if applicable) None....
Awaiting development Reference number: GID-TA10519 Expected publication date: TBC
Tezepelumab for treating severe chronic rhinosinusitis with nasal polyps ID6379
In development Reference number: GID-TA11429 Expected publication date: 09 September 2026
This guideline covers managing COVID-19 in babies, children, young people and adults in community and hospital settings. It includes recommendations on communication, assessment, therapeutics for COVID-19, non-invasive respiratory support, preventing and managing acute complications, and identifying and managing co-infections.
the UK:- What interventions, approaches and methodologies provided by social care and voluntary sectorservices are effective and cost...
Support for delivering quality, safety and efficiency in the optimisation of medicines.
Obsessive-compulsive disorder and body dysmorphic disorder: treatment (CG31)
This guideline covers recognising, assessing, diagnosing and treating obsessive-compulsive disorder and body dysmorphic disorder in adults, young people and children (aged 8 years and older). It aims to improve the diagnosis and treatment of obsessive-compulsive disorder and body dysmorphic disorder. It includes recommendations on how families and carers may be able to support people with either of these conditions, and how they can get support for themselves.
In development Reference number: GID-TA11554 Expected publication date: TBC
This manual explains the processes and methods used to develop and update NICE guidelines, the guidance that NICE develops covering topics across clinical care (in primary, secondary and community care settings), social care and public health. For more information on the other types of NICE guidance and advice (including technology appraisal guidance), see about NICE
Generalised anxiety disorder and panic disorder in adults: management (CG113)
This guideline covers the care and treatment of people aged 18 and over with generalised anxiety disorder (chronic anxiety) or panic disorder (with or without agoraphobia or panic attacks). It aims to help people achieve complete relief of symptoms (remission), which is associated with better functioning and a lower likelihood of relapse.
Hepatocellular carcinoma (unresectable, untreated) - tislelizumab [ID6129]
Awaiting development Reference number: GID-TA11218 Expected publication date: TBC